|
Authored by:
- Lindsay Cashio
|
Estimated read time: 1 minute
Choose the health content that's right for you, and get it delivered right in your inbox
Nearly 200 guests recently joined the AdventHealth Waterman Foundation for the milestone 10th annual Celebration of Life Gala.
The evening at the Orlando Science Center raised more than $106,000 to support the hospital’s emergency services expansion and included a gourmet dinner, silent auction, entertainment by SAK Comedy Lab and a special drawing for a pair of garnet and diamond earrings.
“Originally built to accommodate 50,000 patients a year, our AdventHealth Waterman emergency department cared for nearly 66,500 patients in 2018. These consistently high volumes show a clear community need to expand our ER to care for patients who turn to us during their greatest time of need,” said April Kauffman, AdventHealth Waterman Foundation president. “Through the generosity of our donors, we can help ensure patients continue to receive the very best care in a safe and compassionate environment.”
The AdventHealth Waterman Foundation is currently engaged in a $5 million capital campaign to support the hospital’s ongoing construction project to expand the emergency department. All proceeds from the gala will support this campaign.
Expanding emergency services and facilities at the hospital aims to improve patient access and satisfaction, reduce wait times, provide greater privacy and enhance patient safety.
The first phase of the project will open in April of 2019.
Recent News
-
Our Communities
UChicago Medicine AdventHealth team members and physicians provided health screenings, medical services and community connections at the Glendale Heights mission clinic.
-
Our Communities
A state-of-the-art hospital that will offer leading-edge treatments to patients from Central Florida and around the globe is coming to Lake Nona in Central Florida.
-
Our Communities
A new way of treating bladder cancer is revolutionizing the field. AdventHealth Cancer Institute is the only site in Florida and first in the U.S. to open this treatment via a trial.